Couselling to improve symptoms of anxiety or depression for heart transplant recipients

Not Applicable

Completed

• Conditions: Cardiovascular - Other cardiovascular diseases; Mental Health - Anxiety; Anxiety; Heart Transplant; Depression; Mental Health - Depression

• Registration Number: ACTRN12613000740796
• Lead Sponsor: Queensland University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-07-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

For screening: Heart transplant recipients aged over 18 years who are scheduled for a routine outpatient consultation with the Heart Transplant Nurse Practitioner at The Prince Charles Hospital (TPCH).
For randomization: Participants who score more than 5 on the GAD-7 or the PHQ-9, which indicates at least mild symptoms of anxiety or depression, but who are not currently receiving regular psychological therapy from a mental health practitioner.

Exclusion Criteria

Heart transplant recipients less than three months post transplant as well as those who are cognitively impaired (as confirmed by a treating clinician), unable to understand and speak English, have a diagnosed major psychiatric comorbidity (schizophrenia, bipolar, dementia) or have a terminal illness (such as cancer).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary objective of this study is to assess the feasibility of telephone-delivered cognitive behaviour therapy followed by case conferencing with specialist and primary care services in improving psychological and clinical outcomes for heart transplant recipients. Assessment of feasibility includes recruitment issues, likely attrition rates and acceptability of interventions (measured by dropout rates due to the nature of intervention during the study), which are important considerations in planning a larger clinical trial. It will also help determine the effect size for sample size estimation to adequately power a future larger clinical trial.[9 weeks and 6 months]